Elsbree David B 4
4 · T2 Biosystems, Inc. · Filed Jan 7, 2020
Insider Transaction Report
Form 4
Elsbree David B
Director
Transactions
- Sale
Common Stock
2020-01-03$1.16/sh−5,316$6,167→ 91,081 total
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2019, to cover payment of tax liability incident to the vesting of restricted stock units.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.14 to $1.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.